We are live on ! Find out more
SWTX

SpringWorks Therapeutics
SWTX

Delisted

SWTX was delisted on the 30th of June, 2025.

Back to rankings

148 hedge funds and large institutions have $1.64B invested in SpringWorks Therapeutics in 2022 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 56 increasing their positions, 44 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

939% more call options, than puts

Call options by funds: $20.8M | Put options by funds: $2.01M

75% more funds holding in top 10

Funds holding in top 10: 4 → 7 (+3)

35% more capital invested

Capital invested by funds: $1.21B → $1.64B (+$428M)

32% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 19

27% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 44

3% more funds holding

Funds holding: 143 → 148 (+5)

10.49% less ownership

Funds ownership: 111.87% → 101.38% (-10%)

Holders
148
Holders Change
+5
Holders Change %
+3.5%
% of All Funds
2.55%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.12%
New
25
Increased
56
Reduced
44
Closed
19
Calls
$20.8M
Puts
$2.01M
Net Calls
+$18.8M
Net Calls Change
+$19.4M

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$99.2M
2
DTC
Deep Track Capital
Connecticut
+$67.9M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$55.9M
4
BC
Boxer Capital
California
+$38.6M
5
AG
Artal Group
Luxembourg
+$33.1M

Top Sellers

Rank Fund Capital Flow
1
DCM
Driehaus Capital Management
Illinois
-$25.6M
2
ACH
ArrowMark Colorado Holdings
Colorado
-$21.4M
3
State Street
State Street
Massachusetts
-$16.2M
4
O
OrbiMed
New York
-$14.4M
5
Nomura Holdings
Nomura Holdings
Japan
-$13.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Norges Bank
26
Norges Bank
Norway
$10.2M -$4.42M -154,199 -30%
Northern Trust
27
Northern Trust
Illinois
$8.8M +$228K +7,966 +3%
FC
28
Finepoint Capital
Massachusetts
$8.79M +$8.83M +308,092 New
SFM
29
Sphera Funds Management
Israel
$8.61M -$6.74M -235,039 -44%
DCM
30
Driehaus Capital Management
Illinois
$7.82M -$25.6M -891,713 -76%
T. Rowe Price Associates
31
T. Rowe Price Associates
Maryland
$7.1M +$213K +7,412 +3%
Rafferty Asset Management
32
Rafferty Asset Management
New York
$6.97M +$2M +69,660 +40%
Bessemer Group
33
Bessemer Group
New Jersey
$6.88M – – –
Charles Schwab
34
Charles Schwab
California
$6.78M +$905K +31,560 +15%
Citigroup
35
Citigroup
New York
$6.4M -$850K -29,632 -12%
New York State Common Retirement Fund
36
New York State Common Retirement Fund
New York
$5.95M +$544K +18,985 +10%
AAA
37
Affinity Asset Advisors
New York
$4.99M +$5.02M +175,000 New
CSS
38
Cubist Systematic Strategies
Connecticut
$4.88M +$986K +34,386 +25%
Millennium Management
39
Millennium Management
New York
$4.87M +$3.07M +106,925 +168%
Citadel Advisors
40
Citadel Advisors
Florida
$4.76M +$1.08M +37,580 +29%
CS
41
Candriam SCA
Luxembourg
$4.63M – – –
Two Sigma Advisers
42
Two Sigma Advisers
New York
$4.37M +$132K +4,600 +3%
Barclays
43
Barclays
United Kingdom
$4.35M +$3.99M +139,337 +1,069%
Bank of New York Mellon
44
Bank of New York Mellon
New York
$4.29M +$652K +22,733 +18%
Adage Capital Partners
45
Adage Capital Partners
Massachusetts
$4.28M -$12.2M -425,000 -74%
D.E. Shaw & Co
46
D.E. Shaw & Co
New York
$4.15M -$2.86M -99,853 -41%
Ameriprise
47
Ameriprise
Minnesota
$4.09M +$4.11M +143,386 New
TCM
48
Tang Capital Management
California
$3.42M +$3.44M +120,000 New
Two Sigma Investments
49
Two Sigma Investments
New York
$3.3M -$5.93M -206,993 -64%
N
50
Nuveen
North Carolina
$3.16M -$34.6K -1,208 -1%
1
2
3 4 5

SWTX Hedge Fund Activity: Q3 2022 in Review

148 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q3 2022, worth a combined $1.64B — up 35% from $1.21B a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new SWTX positions and 19 closed out — a net gain of 6 holders — while 56 added to existing stakes and 44 trimmed.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $99.2M. The largest seller was Driehaus Capital Management, cutting an estimated $25.6M.

  • 148 institutional investors held SpringWorks Therapeutics (SWTX) as of Q3 2022, up from 143 in Q2 2022.
  • Funds reported $1.64B of SpringWorks Therapeutics stock for Q3 2022, up 35% quarter-over-quarter.
  • 25 funds opened new SpringWorks Therapeutics positions in Q3 2022 and 19 closed out, a net change of +6 holders.
  • The largest SpringWorks Therapeutics buyer in Q3 2022 was EcoR1 Capital, an estimated $99.2M added.
  • The largest SpringWorks Therapeutics seller in Q3 2022 was Driehaus Capital Management, an estimated $25.6M sold.

Based on aggregated 13F filings for Q3 2022.